Bristol-Myers gets EU approval for diabetes drugTRENTON, N.J. — Drugmaker Bristol-Myers Squibb Co. said Monday that its new diabetes drug, Onglyza, has been approved for sale in the European Union's 27 countries.

LONDON - People suffering from diabetes are struggling to cope with regular low blood sugar attacks, according to a new British survey.